Target-mediated drug disposition model: relationships with indirect response models and application to population PK–PD analysis

被引:0
作者
Leonid Gibiansky
Ekaterina Gibiansky
机构
[1] QuantPharm LLC,
[2] ICON Development Solutions,undefined
来源
Journal of Pharmacokinetics and Pharmacodynamics | 2009年 / 36卷
关键词
Indirect-response models; Michaelis–Menten approximation; Nonlinear pharmacokinetics; Pharmacodynamics; Quasi-steady-state approximation; Target-mediated drug disposition;
D O I
暂无
中图分类号
学科分类号
摘要
The paper focuses on approximations of the target-mediated drug disposition (TMDD) model as applied to pharmacodynamic (target kinetics) modeling. The TMDD equation for the total target concentration is shown to coincide with the indirect response model with stimulation or inhibition of elimination. This correspondence allows estimation of pharmacodynamic TMDD parameters and unobservable free target concentrations using indirect-response models. The ability of the TMDD model and its approximations to estimate the unobservable free target concentration is investigated by simulation. Pharmacokinetic parameters used for simulations were parameters typical for monoclonal antibodies. TMDD binding and target turnover parameters were similar to those estimated for omalizumab. Free drug and total target concentrations were measured. The simulated population PK–PD study demonstrated that for drugs with TMDD, indirect-response models are in fact mechanistic models that can be used to estimate TMDD model parameters and unobservable free target concentrations that are important for pharmacodynamic modeling.
引用
收藏
页码:341 / 351
页数:10
相关论文
共 29 条
  • [1] Mager DE(2001)General pharmacokinetic model for drugs exhibiting target-mediated drug disposition J Pharmacokinet Pharmacodyn 28 507-532
  • [2] Jusko WJ(2005)Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition Pharm Res 22 1589-1596
  • [3] Mager DE(2008)Approximations of the target-mediated drug disposition model and identifiability of model parameters J Pharmacokinet Pharmacodyn 35 573-591
  • [4] Krzyzanski W(2009)Target-mediated drug disposition model: approximations, identifiability of model parameters, and applications to the population pharmacokinetic––pharmacodynamic modeling of biologics Expert Opinion Drug Metab Toxicol 5 803-812
  • [5] Gibiansky L(1993)Comparison of four basic models of indirect pharmacodynamic responses J Pharmacokinet Biopharm 21 457-478
  • [6] Gibiansky E(1999)Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis J Pharmacokinet Biopharm 27 397-420
  • [7] Kakkar T(2007)A review of the pharmacokinetics and pharmacodynamics of monoclonal antibodies––mechanistic modeling applied to drug development Current Opinion Drug Discov Devel 10 84-96
  • [8] Ma P(2008)Monoclonal antibody pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 84 548-558
  • [9] Gibiansky L(2005)On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach Basic Clin Pharmacol Toxicol 96 182-192
  • [10] Gibiansky E(2007)A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab Br J Clin Pharmacol 63 548-561